"LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss." Cell Metab
Some people taking GLP-1 medications may experience digestive side effects, with these being the most common: Nausea, especially at the start or after a dose increase Heartburn or stomach discomfort after meals Constipation, which can occur as the body adjusts Diarrhea, which may be mild or bothersome Vomiting, sometimes along with nausea Most digestive side effects lessen as the body adjusts
Trulicity is not approved for use by anyone younger than 10 years old with type 2 diabetes
Starting Retatrutide alone removes the guesswork
This peptide calms that alarm, with data showing a potential 50% reduction in inflammatory markers like IL-6
This dramatically compromises metabolic rate, body composition, and long-term weight maintenance